Primary information |
---|
ID | antitb_1318, |
Name | 21464254 |
N-Terminal modification | Peptoid 1 |
C-Terminal Modification | H-(NLys-Nspe-Nspe)4-NH2 |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | Nlys = N-(4-aminobutyl)glycine, Nspe = (S)-N-(1-phenylethyl)glycine |
Chirality | Linear |
Nature | 12 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
Cell Line | MIC = 14.1μM |
Inhibition Concentration | In vitro |
Sequence | 2011 |
Cytotoxicity | Raw 264.7 and J774 mouse macrophage |
In vivo Model | NA |
Lethal Dose | LD50 = 14.1μM |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1324, |
Name | 21464254 |
N-Terminal modification | Peptoid 1 |
C-Terminal Modification | H-(NLys-Nspe-Nspe)4-NH2 |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | Nlys = N-(4-aminobutyl)glycine, Nspe = (S)-N-(1-phenylethyl)glycine |
Chirality | Linear |
Nature | 12 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium bovis |
In Vitro/ In vivo | Mycobacterium bovis BCG |
Cell Line | MIC = 12.5-25 μM |
Inhibition Concentration | In vitro |
Sequence | 2011 |
Cytotoxicity | Raw 264.7 and J774 mouse macrophage |
In vivo Model | NA |
Lethal Dose | LD50 = 14.1μM |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |